Join
Live feed
·
INSIDERFilingvia Quantisnow
Arrowhead Pharmaceuticals Inc. logo

Chief Executive Officer Anzalone Christopher Richard was granted 180,000 shares and sold $12,348,802 worth of shares (184,298 units at $67.00), decreasing direct ownership by 0.11% to 3,916,957 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ARWR· Arrowhead Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARWR (Arrowhead Pharmaceuticals Inc.) and more on Quantisnow.